
Bipolar disorder is a complex neurobiological condition characterized by significant mood episodes ranging from depression to mania or hypomania, requiring sophisticated psychiatric expertise for accurate diagnosis and effective treatment. As a board-certified bipolar psychiatrist with dual MD/PhD credentials in neuroscience, Dr. Gabriella Farkas provides comprehensive evaluation, precise diagnosis, and evidence-based bipolar medication management for adults throughout South Carolina, New York, and Virginia via secure telehealth. Her specialized training at Zucker Hillside Hospital—one of only four NIH-designated research centers for serious mental illness—and her pharmaceutical research experience developing psychiatric medications provide exceptional expertise in managing this challenging condition.
Dr. Farkas’s neuroscience background provides deep understanding of the neurobiological mechanisms underlying bipolar disorder—how dysregulation in mood-regulating brain circuits, neurotransmitter systems, and circadian rhythm pathways creates the characteristic mood instability. This scientific foundation enables precise medication selection for mood stabilization treatment, helping individuals achieve stable mood and improved functioning. The National Institute of Mental Health recognizes bipolar disorder as a serious but treatable medical condition requiring expert psychiatric care and, in most cases, long-term medication management for optimal outcomes.
Bipolar disorder differs fundamentally from typical mood fluctuations everyone experiences. This neurobiological condition involves distinct mood episodes—periods of depression, mania, or hypomania—that represent significant departures from a person’s baseline functioning. These episodes aren’t simply feeling happy or sad; they involve changes in energy, activity levels, sleep, thinking patterns, and behavior that can significantly impair functioning and, during severe episodes, require hospitalization.
Bipolar disorder results from dysfunction in brain circuits regulating mood, energy, and circadian rhythms. Neuroimaging studies show structural and functional differences in regions including the prefrontal cortex, amygdala, and hippocampus. Neurotransmitter dysregulation—particularly involving dopamine, serotonin, norepinephrine, and glutamate—contributes to mood episodes. Genetic factors play a significant role; bipolar disorder has one of the highest heritability rates among psychiatric conditions. Disrupted circadian rhythm regulation affects sleep-wake cycles and can trigger mood episodes. These neurobiological differences aren’t character flaws or failures of willpower—they’re medical conditions requiring professional bipolar disorder treatment.
Several distinct forms of bipolar disorder exist, each with specific diagnostic criteria and treatment considerations:
Accurate diagnosis requires understanding the distinct characteristics of manic, hypomanic, and depressive episodes:
A manic episode represents a distinct period of abnormally elevated, expansive, or irritable mood, along with increased energy or goal-directed activity. Symptoms include:
Hypomania involves the same types of symptoms as mania but less severe and shorter duration (at least four consecutive days). The key distinction: hypomania doesn’t cause severe impairment or require hospitalization, and psychotic features are absent. However, hypomania still represents a noticeable change from baseline functioning and often precedes or follows depressive episodes.
Depressive episodes in bipolar disorder are indistinguishable from major depression and include:
Importantly, individuals with bipolar disorder typically spend far more time depressed than manic or hypomanic—depression represents the predominant symptom burden and causes most of the functional impairment and suffering.
Common triggers for mood episodes include sleep disruption (perhaps the most potent trigger), stressful life events, seasonal changes (spring often triggers mania), medication changes or non-adherence, substance use (particularly stimulants or excessive alcohol), and disrupted routines or travel across time zones.
Many individuals with bipolar disorder go years before receiving accurate diagnosis, often initially misdiagnosed with unipolar depression. Consider seeking evaluation from a bipolar psychiatrist if you experience:
Accurate diagnosis of bipolar disorder requires comprehensive psychiatric evaluation by an experienced psychiatrist. Misdiagnosis is common, with many individuals initially diagnosed with unipolar depression, anxiety, ADHD, or personality disorders. Dr. Farkas’s diagnostic process ensures precision:
Your initial evaluation includes detailed exploration of mood episode history—characteristics, duration, frequency, and impact of both elevated and depressed periods. Dr. Farkas gathers information about sleep patterns during different mood states, energy and activity level changes, thinking and speech patterns, impulsive or risky behaviors during elevated periods, previous psychiatric treatment responses (especially antidepressant reactions), substance use and its relationship to mood, family psychiatric history (bipolar disorder, depression, suicide, substance use), medical conditions and medications, and psychosocial stressors and supports.
Understanding your mood pattern over time is crucial for accurate diagnosis. Dr. Farkas may construct a lifetime mood chart identifying when episodes occurred, their duration, severity, and what triggered or resolved them. This longitudinal perspective distinguishes bipolar disorder from other conditions with mood instability.
Dr. Farkas uses standardized mood rating scales measuring both depressive and manic symptom severity. Instruments like the Mood Disorder Questionnaire screen for bipolar features, while other scales track current symptom levels and treatment response over time. This measurement-based approach increases diagnostic accuracy.
Many conditions can mimic bipolar disorder or coexist with it. Dr. Farkas carefully evaluates for unipolar depression with agitation (appears similar but treated differently), borderline personality disorder (mood instability but different pattern), ADHD (impulsivity and distractibility overlap with mania), substance-induced mood disorder (stimulants, steroids, antidepressants can cause manic symptoms), medical conditions (hyperthyroidism, neurological conditions), and schizoaffective disorder (when psychotic symptoms occur outside mood episodes). Her research center training and diagnostic expertise enable accurate differentiation.
Certain medical conditions can cause mood symptoms mimicking bipolar disorder. Dr. Farkas may recommend medical evaluation for thyroid function, neurological disorders, medication side effects, or other potential medical contributors, coordinating with your primary care physician when appropriate.
With your permission, information from family members or close friends can be invaluable, as individuals experiencing mania or hypomania often lack insight that their behavior has changed. Loved ones may recognize mood episodes you don’t remember clearly or characterize differently.
Effective bipolar disorder treatment almost always requires medication—unlike many psychiatric conditions where therapy alone may be sufficient, bipolar disorder’s neurobiological nature necessitates pharmacological intervention for most individuals. Dr. Farkas specializes in sophisticated bipolar medication management, the cornerstone of treatment. Many patients benefit from combining her medication expertise with separate therapy from psychologists or counselors who provide psychoeducation, coping strategies, and support.
Medications for mood stabilization treatment work by regulating neurobiological dysregulation underlying mood episodes. Without medication, most individuals with bipolar disorder experience recurring episodes that become more frequent and severe over time (a phenomenon called “kindling”). Untreated bipolar disorder causes profound functional impairment, relationship damage, occupational problems, financial devastation from manic spending, substance abuse, and significantly elevated suicide risk. Effective medication prevents episodes, reduces their severity when they occur, and enables stable functioning. The Substance Abuse and Mental Health Services Administration emphasizes that medication management is the foundation of bipolar disorder treatment, with psychotherapy serving as an important adjunct.
Mood stabilizers represent first-line treatment for bipolar disorder, preventing both manic and depressive episodes:
Lithium: The oldest and most extensively studied mood stabilizer, lithium remains the gold standard for bipolar treatment due to its effectiveness in preventing both manic and depressive episodes and reducing suicide risk—the only psychiatric medication proven to decrease suicide. Lithium requires regular blood level monitoring to ensure therapeutic dosing while avoiding toxicity, along with monitoring kidney and thyroid function. While monitoring requirements are more intensive than some medications, lithium’s effectiveness makes it worth considering, especially for classic Bipolar I presentations. Dr. Farkas’s medical training and careful monitoring protocols ensure safe lithium management when appropriate.
Valproate (Divalproex): An anticonvulsant with excellent mood-stabilizing properties, particularly effective for mixed episodes and rapid cycling bipolar disorder. Requires blood level monitoring and periodic liver function tests. Generally well-tolerated with manageable side effects. Note: Cannot be used during pregnancy due to birth defect risks.
Lamotrigine: Particularly effective for preventing depressive episodes in bipolar disorder—valuable since depression represents the predominant symptom burden for most individuals. Less effective for acute mania but excellent for maintenance treatment, especially Bipolar II. Requires slow titration to prevent rare but serious rash. Generally well-tolerated with minimal weight gain or cognitive effects.
Carbamazepine: Another anticonvulsant with mood-stabilizing properties, effective for some individuals who don’t respond to other mood stabilizers. Requires blood level monitoring and has significant drug interactions requiring careful management.
Second-generation antipsychotics are highly effective for mood stabilization treatment, particularly for acute mania and maintenance treatment:
Cariprazine: Dr. Farkas has unique expertise with this medication, having worked as a pharmaceutical research fellow on the SCHIZOBANK initiative that helped develop it. FDA-approved for bipolar mania, bipolar depression, and schizophrenia, cariprazine offers distinctive pharmacology with potentially fewer metabolic side effects than some alternatives.
Quetiapine: FDA-approved for bipolar mania, bipolar depression, and maintenance treatment. Effective for both poles of bipolar disorder. Sedating effects can help with sleep, though metabolic side effects require monitoring.
Lurasidone: Specifically FDA-approved for bipolar depression—valuable since treating depressive episodes in bipolar disorder is particularly challenging. Generally better metabolic profile than some alternatives.
Aripiprazole, Olanzapine, Risperidone, Ziprasidone: All FDA-approved for various phases of bipolar treatment with different side effect profiles. Dr. Farkas’s pharmaceutical research experience and pharmacology expertise enable informed selection among these options based on individual patient factors.
Antidepressants for bipolar depression require extremely careful consideration. While they can help depressive symptoms, antidepressants used alone (without mood stabilizers) risk triggering mania, hypomania, or rapid cycling. Dr. Farkas prescribes antidepressants for bipolar depression only when:
Her sophisticated understanding of when antidepressants help versus harm in bipolar disorder prevents common treatment errors less experienced prescribers make.
Anti-anxiety medications like benzodiazepines can provide short-term relief during acute manic agitation or severe anxiety but aren’t primary treatments. Dr. Farkas uses them judiciously as adjuncts when appropriate, with her “no harm” philosophy guiding decisions about their risks versus benefits.
Managing medications for bipolar disorder requires sophisticated expertise—this is one of the most challenging psychiatric conditions to treat effectively. Dr. Farkas’s approach optimizes outcomes:
No single medication regimen works for everyone with bipolar disorder. Dr. Farkas considers your specific bipolar type (I, II, cyclothymic), predominant symptom polarity (more manic or more depressed), presence of mixed features or rapid cycling, history of antidepressant responses, psychotic features, medical conditions and drug interactions, side effect concerns and tolerability priorities, pregnancy plans (many mood stabilizers affect fetal development), and previous medication trials and responses when selecting initial treatment. Her neuroscience training and pharmaceutical research experience enable sophisticated, evidence-based decisions tailored to individual presentations.
Bipolar medication management involves two phases with different goals:
Acute Treatment: During active mood episodes, medications aim to resolve current mania, hypomania, or depression as quickly and safely as possible. May require higher doses or medication combinations, frequent monitoring and dose adjustments, and sometimes short-term use of additional medications for sleep, agitation, or anxiety.
Maintenance Treatment: After mood stabilization, focus shifts to preventing future episodes. Requires long-term (often lifelong) medication continuation at doses proven effective for you, regular monitoring even when feeling well, and adjustment of treatment at first signs of emerging episodes. Most individuals require maintenance treatment indefinitely, as discontinuing mood stabilizers leads to high recurrence rates.
Many individuals with bipolar disorder require multiple medications for optimal mood stabilization treatment—for example, mood stabilizer plus atypical antipsychotic, two mood stabilizers, or mood stabilizer plus antidepressant (carefully monitored). Dr. Farkas’s experience with complex medication regimens and understanding of drug interactions enables sophisticated combination strategies when monotherapy proves insufficient.
Some mood stabilizers require regular monitoring including blood level checks (lithium, valproate, carbamazepine to ensure therapeutic levels), kidney function monitoring (lithium), liver function tests (valproate), thyroid function (lithium can affect thyroid), metabolic monitoring (weight, blood sugar, lipids for antipsychotics), and complete blood counts (carbamazepine). Dr. Farkas follows evidence-based monitoring protocols ensuring medication safety while catching potential problems early.
Mood stabilizers can cause side effects affecting tolerability and adherence. Common issues include weight gain (particularly with some antipsychotics and valproate), cognitive effects or “mental fog” with some medications, tremor (particularly lithium), gastrointestinal upset, sedation or fatigue, metabolic changes (blood sugar, cholesterol), or hormonal effects. Dr. Farkas proactively addresses side effects through dose adjustments, timing modifications, switching to alternative medications with different side effect profiles, adding medications to counteract specific side effects when appropriate, and lifestyle interventions. Her “no harm” philosophy means not tolerating significant side effects when alternatives exist—though she also educates patients about balancing tolerability against the serious consequences of inadequately treated bipolar disorder.
Some individuals don’t achieve adequate stability with first-line treatments. Dr. Farkas’s elite training at an NIH research center specializing in treatment-resistant cases provides expertise with advanced strategies including novel medication combinations, high-dose strategies when evidence-based and safe, clozapine (the most effective antipsychotic for treatment-resistant cases, though requiring specialized monitoring), electroconvulsive therapy (ECT) referrals when appropriate—one of the most effective treatments for severe bipolar depression, and systematic evaluation of whether adherence issues, substance use, medical conditions, or misdiagnosis contribute to poor response.
While Dr. Farkas specializes in bipolar medication management rather than providing therapy, she recognizes that optimal bipolar disorder treatment includes complementary approaches:
Evidence-based therapies specifically for bipolar disorder include psychoeducation (learning about the illness, triggers, early warning signs), cognitive-behavioral therapy adapted for bipolar disorder, interpersonal and social rhythm therapy (emphasizing routine stabilization), and family-focused therapy (educating families and improving communication). Dr. Farkas can recommend qualified therapists specializing in bipolar disorder when appropriate.
Certain lifestyle factors profoundly affect bipolar disorder stability:
Sleep Regulation: Perhaps the most important factor. Maintaining consistent sleep-wake schedules, getting adequate sleep (7-9 hours), and avoiding sleep deprivation (a potent mania trigger) is essential. Even one night of significantly reduced sleep can trigger mood episodes in vulnerable individuals.
Routine and Structure: Regular daily routines—consistent meal times, activity schedules, and social rhythms—help stabilize circadian systems and prevent mood destabilization.
Substance Avoidance: Alcohol and recreational drugs (particularly stimulants) can trigger mood episodes, interfere with medications, and worsen course. Sobriety significantly improves outcomes.
Stress Management: While stress is inevitable, developing effective coping strategies, recognizing limits, and managing stress proactively prevents stress-triggered episodes.
Exercise: Regular physical activity benefits mood stability, though excessive exercise during hypomania/mania should be monitored as a potential symptom rather than healthy behavior.
Learning to recognize early signs of emerging episodes—sleep changes, irritability, increased energy, racing thoughts, decreased need for sleep, loss of interest, increased anxiety—enables early intervention preventing full episode development. Dr. Farkas helps patients identify their personal warning signs and develop action plans.
Bipolar disorder frequently coexists with other psychiatric conditions complicating diagnosis and treatment:
ADHD occurs in approximately 20% of individuals with bipolar disorder. Distinguishing between the two is challenging since both involve impulsivity, distractibility, and hyperactivity. Key differences: ADHD symptoms are chronic and stable, while bipolar symptoms are episodic. Dr. Farkas’s diagnostic expertise enables accurate identification when both conditions coexist, with treatment typically prioritizing mood stabilization before addressing ADHD.
Anxiety disorders are extremely common in bipolar disorder, affecting 50-70% of individuals. Anxiety can be part of mood episodes (particularly mixed episodes) or represent separate anxiety disorders. Treating mood episodes often improves anxiety, though separate anxiety treatment may be necessary.
Approximately 60% of individuals with bipolar disorder experience substance use problems at some point—dramatically higher than general population. Substance use may represent self-medication attempts, result from impaired judgment during mania, or occur as comorbid addiction. While Dr. Farkas doesn’t provide specialized addiction treatment, she addresses bipolar disorder in individuals with stable recovery and coordinates with addiction specialists when appropriate.
Individuals with bipolar disorder have elevated rates of cardiovascular disease, diabetes, thyroid disorders, and migraines. Some mood stabilizers affect metabolism, requiring monitoring. Dr. Farkas coordinates with medical providers ensuring comprehensive care addressing both psychiatric and medical needs.
Bipolar disorder in women requires special considerations regarding menstrual cycle effects (symptoms often worsen premenstrually), pregnancy planning (some mood stabilizers cause birth defects; careful planning necessary), pregnancy and postpartum (highest risk period for mood episodes; specialized treatment planning essential), and menopause (hormonal changes can destabilize mood). Dr. Farkas’s perinatal psychiatry training enables expert navigation of these complex decisions, including risk-benefit analysis of continuing versus discontinuing mood stabilizers during pregnancy.
Late-life bipolar disorder includes both individuals with long-standing illness and those with late-onset bipolar disorder (first episode after age 50). Older adults require careful medication selection accounting for medical comorbidities, drug interactions with medical treatments, increased sensitivity to side effects, and cognitive concerns. Dr. Farkas’s geriatric psychiatry expertise ensures age-appropriate treatment.
Bipolar II disorder is frequently misdiagnosed as unipolar depression because hypomanic episodes may not be recognized as problematic—hypomania can feel good, and individuals may not report these periods. However, Bipolar II causes significant suffering from depressive episodes and requires mood stabilizers, not antidepressants alone. Dr. Farkas’s diagnostic skills ensure Bipolar II is accurately identified and appropriately treated.
Adults throughout Hilton Head, Bluffton, Beaufort County, and South Carolina seeking expert bipolar disorder treatment choose Dr. Farkas because her qualifications uniquely position her to manage this complex condition:
Elite Training in Serious Mental Illness: Residency at Zucker Hillside Hospital, one of only four NIH research centers for schizophrenia and serious mental illness, provided specialized training in complex bipolar disorder, treatment-resistant cases, and advanced medication strategies most psychiatrists never receive.
Neuroscience Expertise: Her PhD in neuroscience provides deep understanding of bipolar disorder’s neurobiological mechanisms and how mood stabilizers work at the molecular level—knowledge translating to better treatment decisions.
Pharmaceutical Research Background: Direct experience developing psychiatric medications, including work on cariprazine (approved for bipolar mania and depression), provides insider knowledge of medication development, mechanisms, and optimal use.
Diagnostic Precision: Accurately distinguishing bipolar disorder from conditions that mimic it (unipolar depression, borderline personality disorder, ADHD) ensures appropriate treatment from the start—preventing years of ineffective treatment pursuing wrong diagnosis.
Measurement-Based Approach: Using validated mood rating scales rather than subjective impressions enables objective tracking of treatment response and early detection of emerging episodes.
Comprehensive Experience: Over 10 years treating thousands of patients with bipolar disorder across severity spectrum—from stable maintenance to acute hospitalizations—provides breadth and depth of expertise.
Telehealth Convenience: Receive expert care from home, particularly valuable during depressive phases when leaving home feels overwhelming or during subtle mood elevation when you might not recognize need for appointment.
Taking the first step toward expert evaluation and treatment for suspected or diagnosed bipolar disorder is straightforward:
If you’ve experienced dramatic mood swings, periods of decreased sleep with increased energy and productivity followed by depressive crashes, treatment-resistant depression, or previous psychiatric hospitalizations, you may have bipolar disorder requiring specialized treatment. Accurate diagnosis and expert bipolar medication management can be life-changing—preventing devastating mood episodes, enabling stable functioning, preserving relationships and careers, and dramatically reducing suicide risk.
Dr. Farkas’s rare combination of elite training in serious mental illness, neuroscience expertise, pharmaceutical research experience, and sophisticated medication management skills provides the specialist-level care necessary to effectively treat this challenging condition—even when previous treatments have been inadequate. Don’t spend another year on the mood roller coaster when expert mood stabilization treatment exists.
Ready to achieve mood stability? Contact the practice today to schedule your comprehensive evaluation and begin the journey toward stable mood, improved functioning, and better quality of life—finally experiencing what it’s like to live without the devastating mood episodes that have been controlling your life.
Dr. Farkas’s MD/PhD expertise delivers results when standard treatment hasn’t worked, combining sophisticated medication strategies with her “no harm” philosophy for optimal outcomes with minimal side effects.
Our comprehensive 30-60 minute psychiatric evaluation establishes accurate diagnosis through detailed clinical interview, validated rating scales, and evidence-based treatment planning tailored to your unique presentation.
Follow-up medication management sessions monitor treatment response, optimize medications for maximum benefit with minimal side effects, and adjust your treatment plan based on objective measures and your progress.
Flexible scheduling Monday-Friday with early evening appointments for working professionals.
100% telehealth—all appointments via secure, HIPAA-compliant video from your home.
Secure patient portal for appointment scheduling and non-urgent questions between sessions.
At the heart of Dr. Farkas’s practice is a commitment to scientific rigor and the principle of “do no harm.” With rare dual MD/PhD credentials in neuroscience and pharmaceutical research experience developing psychiatric medications, she brings exceptional depth of understanding to every treatment decision—knowledge that translates directly into better outcomes for patients who haven’t found relief with standard approaches. Her training at Zucker Hillside Hospital, one of only four NIH research centers for serious mental illness, provided expertise in the most complex, treatment-resistant cases that typical psychiatric residencies never encounter. But credentials alone aren’t enough—Dr. Farkas treats patients as intelligent partners in their own care, taking time to explain the science behind recommendations and using validated rating scales to track progress objectively rather than relying on guesswork. Her “no harm” philosophy means actively working to minimize side effects and unnecessary medications, not just suppressing symptoms at any cost. This approach, combined with the option for secure telehealth appointments, brings academic medical center-quality expertise to the Lowcountry without the barriers of travel, long waits, or rushed appointments. When standard treatment hasn’t worked, expertise truly matters—and Dr. Farkas’s unique combination of scientific knowledge, clinical experience, and genuine commitment to patient partnership makes the difference between continuing to struggle and finally getting better.
We’re here to support you with compassion, clinical expertise, and personalized care—every step of the way. From your first consultation to ongoing treatment, our dedicated team takes the time to understand your unique needs, ensuring that you feel heard, valued, and empowered throughout your mental health journey.